✦ LIBER ✦

Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

✍ Scribed by Ute E Krainick-Strobel; Werner Lichtenegger; Diethelm Wallwiener; Augustinus H Tulusan; Fritz Jänicke; Gunther Bastert; Ludwig Kiesel; Birgit Wackwitz; Stefan Paepke

Book ID: 115011480
Publisher: BioMed Central
Year: 2008
Tongue: English
Weight: 275 KB
Volume: 8
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-8-62

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot Trial of Preoperative (Neoadjuvant

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer

✍ Andres Forero-Torres; Mansoor N. Saleh; Janice A. Galleshaw; Cheryl F. Jones; Ja 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 661 KB

A randomized phase III trial of adjuvant

A randomized phase III trial of adjuvant endocrine therapy with tamoxifen for one year (TAM1) vs tamoxifen for two years (TAM2) in postmenopausal high risk patients with estrogen receptor positive or estrogen receptor unknown breast cancer. A DBCG study

✍ J. Andersen; M. Andersson; K.W. Andersen; P. Dombemowsky; H.T. Mouridsen; C. Ros 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 300 KB